Icariin alleviates high‐fat diet‐induced nonalcoholic fatty liver disease via up‐regulating miR‐206 to mediate NF‐κB and MAPK pathways

RMRP inhibition prevents NAFLD progression in rats via regulating miR-206/PTPN1 axis

(2022) Jingjing Yin et al.   MAMMALIAN GENOME

LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis

(2022) Juan Xiang et al.   Frontiers in Bioengineering and Biotechnology

FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling

(2021) Wenzhou Ding et al.   Frontiers in Oncology

miR-21-5p Regulates Mitochondrial Respiration and Lipid Content in H9C2 Cells

(2019) Victoria L. Nasci et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT

(2019) Ke Wang et al.   Journal of Hematology & Oncology

The Role of p38 MAPK in Triacylglycerol Accumulation During Apoptosis

(2019) Nasi Li et al.   PROTEOMICS

miRNAs and NAFLD: from pathophysiology to therapy

(2019) Monika Gjorgjieva et al.   GUT

ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy

(2019) Yuan Tian et al.   Nature Communications

Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway

(2019) Xiaopeng Zhu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Icariin improves SHR erectile function via inhibiting eNOS uncoupling

(2018) Hao Long et al.   ANDROLOGIA

Glycyrrhizin alleviates non-alcoholic steatohepatitis via modulating bile acids and meta-inflammation

(2018) Tingting Yan et al.   DRUG METABOLISM AND DISPOSITION

Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways

(2018) Qiang Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pharmacokinetics of Prenylflavonoids following Oral Ingestion of Standardized Epimedium Extract in Humans

(2018) Yi Teo et al.   PLANTA MEDICA

Current and future pharmacological therapies for NAFLD/NASH

(2017) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis

(2017) Heng Wu et al.   JOURNAL OF HEPATOLOGY

The epidemiology of non-alcoholic fatty liver disease

(2017) Stefano Bellentani   LIVER INTERNATIONAL

Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor

(2017) Wenbo Sun et al.   NEUROSCIENCE LETTERS

Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes

(2015) Lingwen Kong et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

(2015) Erin K. Spengler et al.   MAYO CLINIC PROCEEDINGS

Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1

(2015) Chu-Sook Kim et al.   Nutrition & Metabolism

Swimming improves high-fat induced insulin resistance by regulating lipid and energy metabolism and the insulin pathway in rats

(2014) AN SONG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Icariin Is A PPARα Activator Inducing Lipid Metabolic Gene Expression in Mice

(2014) Yuan-Fu Lu et al.   MOLECULES

MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes

(2013) Dan Zhong et al.   CELLULAR SIGNALLING

Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds

(2013) Min-Hsiung Pan et al.   MOLECULAR NUTRITION & FOOD RESEARCH

MicroRNAs regulating lipid metabolism in atherogenesis

(2012) Katey J. Rayner et al.   THROMBOSIS AND HAEMOSTASIS

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

(2008) Jing SHANG et al.   ACTA PHARMACOLOGICA SINICA